GW Pharmaceuticals Ltd - Company Profile
Powered by
All the data and insights you need on GW Pharmaceuticals Ltd in one report.
- Save hours of research time and resources with
our up-to-date GW Pharmaceuticals Ltd Strategy Report
- Understand GW Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
GW Pharmaceuticals Plc (GW Pharmaceuticals), a subsidiary of Jazz Pharmaceuticals, is a biopharmaceutical company that carries out the research, development, and commercialization of cannabinoid prescription medicines for a range of medical conditions. Focused R&D activities and unique cannabinoid products are its strengths, even as a history of operating losses remains a major cause for concern to the company. GW Pharmaceuticals could benefit from regulatory approvals and unmet medical need for epilepsy. However, competitive pressure, non-compliance with applicable laws and regulations and dependence on a limited customer base could affect the company's results of operation and financial condition.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer